Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Financials
52W LOW $18.0152W HIGH $36.80
Volume
3.38 M
Value Traded
107.25 M
Short % Float
4.84%
Days to Cover
1.0
+1.53%Week
+35.94%1 Month
+34.05%3 Month
+55.35%6 Month
Cash Data
- Monthly Burn
- Burn Trend
- Dilution Risk
- SEC Filing
Key Stats
Market Cap
4.76 B
EPS (TTM)
1.40
P/E Ratio
22.71
Ent. Value
5.62 B
Total Shares
149.83 M
Float Shares
147.17 M
Insiders
1.76%
Institutions
107.00%
Upcoming Catalysts
FDA decisions, readouts and PDUFA dates · scored by probability of approval
| Catalyst | Drug / Treatment | Stage | Prob. of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|
PoA blends historical approval base rates, trial design score and FDA review track record.
OPCH Catalyst Timeline
Dated clinical, regulatory and corporate events for Option Care Health, Inc.
Past FDA Catalysts and PDUFA Decisions
How OPCH actually traded into and out of each decision
| Date | Drug | Catalyst | Stage | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|
| No matching catalysts | ||||||
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision
Drug Pipeline Intelligence
No drug pipeline
Option Care Health, Inc. is a services and tools company (CRO, lab tools or healthcare services). The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.
Clinical Trial Results
Readouts, endpoints and source filings for every OPCH program
| Drug Name | Indication | Phase | Date | Trial Results Summary | Title | Source |
|---|
Inside Trades
| Insider | Side | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Bhatia PrateekOfficer (EVP Sp Sales & Solutions) | Grant/Award | 16,386 16,386 held | $0.00 | 07/06/2026 |
Hedge Fund 13F Activity
Hedge Funds invested in OPCH
| Fund | % of Portfolio | Current MV | Shares Owned | Activity |
|---|---|---|---|---|
| PROSIGHT MANAGEMENT, LP | 1 % (-41.2 %) | 5.68 M | 270.72 K | 32.06% ( 65.72 K) |
Ownership Trends
OPCH Short Interest
Shares sold short, counted twice a month.
4.84%
Short % of Float
of tradable shares sold short
7.1M
Shares Sold Short
-16.9% vs prior count
1.0 Low
Days to Cover
trading days of normal volume to buy every short share back
11.1M
Avg Daily Volume
the average used for days to cover
Options Data
Option Volume
Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg
Option Chain Statistics
| Expiry | Call Vol | Put Vol | Vol P/C | Call OI | Put OI | OI P/C | IV Call | IV Call OI-Wtd | IV Call Vol-Wtd | IV Put | IV Put OI-Wtd | IV Put Vol-Wtd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-20 | ||||||||||||
Real-Time Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last | Vol | OI | Last | Vol | OI | |
| No data available | ||||||
Calls vs Puts by Expiry
CallsPutsLog scale
Competitive positioning
How OPCH ranks across every disease it competes in
Competitive Position is a premium feature
See how OPCH ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trialOPCH News
-OPCH
Nov 4, 2026▲ +0.3%today
Option Care Health Announces Financial Results for the Third Quarter Ended September 30, 2026
Option Care Health reported a strong third quarter for 2026, with net revenue of $1,493.5 million, up 4.1%. GAAP net income rose to $57.4 million, marking a 10.8% increase. The company is set to be acquired by Clayton, Dubilier & Rice, LLC and McKesson Corporation, leading to the withdrawal of its financial guidance.
Read more →-OPCH
Sep 2, 2026Option Care Health to Participate in Upcoming Investor Conferences
Option Care Health, the largest independent provider of home infusion services, announced its participation in two upcoming investor conferences. CEO John Rademacher and CFO Meenal Sethna will represent the company at the Morgan Stanley Global Healthcare Conference and the Deutsche Bank Healthcare Summit in New York City. This engagement highlights the company's commitment to investor relations and market presence.
Read more →-OPCH
Jul 29, 2026▲ +6.5%on this news
Option Care Health Announces Financial Results For The Second Quarter Ended June 30, 2026
Option Care Health announced its financial results for Q2 2026, reporting a net revenue of $1,442 million, up 1.9% year-over-year. The company also saw a GAAP net income increase of 6.7%, reaching $53.9 million. Looking ahead, Option Care Health expects continued growth in revenue and adjusted EBITDA for the full year and Q3 2026, supported by its strategic initiatives.
Read more →-OPCH
Jul 9, 2026Option Care Health to Announce Second Quarter 2026 Financial Results and Host Conference Call
Option Care Health Inc. will announce its second quarter financial results for 2026 on July 29, 2026, before the market opens. A conference call is scheduled for the same day at 8:30 a.m. E.T. to discuss the results. Participants can pre-register for the call or access it via a live audio webcast.
Read more →-OPCH
Jun 4, 2026Option Care Health Appoints Robert Okunski as Vice President, Investor Relations
Option Care Health has appointed Robert Okunski as Vice President of Investor Relations, effective May 26, 2026. Okunski will lead the investor relations strategy and serve as the primary liaison with the investment community. He has extensive experience in various industries and aims to enhance investor engagement and transparency.
Read more →-OPCH
Jun 1, 2026Option Care Health Awarded TIME's World's Most Impactful Companies 2026 Ranking
Option Care Health has been ranked No. 15 on TIME's World's Most Impactful Companies 2026 list. This recognition, based on a rigorous evaluation of measurable positive impacts, underscores the company's commitment to responsible practices. CEO John C. Rademacher emphasized their purpose of providing extraordinary care that changes lives, reflecting the team's daily impact.
Read more →-OPCH
May 12, 2026Extraordinary Care That Changes Lives 2026 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED Option Care Health, Inc. Bank of America Global Healthcare Conference
Option Care Health, Inc. presented a range of financial information, including non-GAAP measures, during the Bank of America Global Healthcare Conference. Management emphasized the importance of these adjusted metrics for providing insights into the company's operational performance and in facilitating comparisons to historical results. However, they also cautioned that actual results might differ from forward-looking statements due to inherent risks and uncertainties, including regulatory changes and market conditions. The presentation included a disclaimer regarding the potential for changes that impact the company's future performance.
Read more →-OPCH
May 4, 2026▲ +5.5%on this news
Option Care Health to Participate in the Bank of America Health Care Conference
Option Care Health, the largest independent provider of home infusion services, will participate in the Bank of America Health Care Conference on May 12, 2026. The event will feature a fireside chat at 10:40am PT/1:40pm ET, providing an opportunity for the company to engage with investors. The webcast will be accessible online.
Read more →-OPCH
Apr 30, 2026▼ -24.3%on this newsshared move
Option Care Health Announces Financial Results for the First Quarter Ended March 31, 2026
Option Care Health reported its financial results for Q1 2026, showing a mixed performance. While net revenue increased by 1.3%, GAAP net income declined by 3.0%. The company has updated its full-year guidance, expecting net revenue between $5.675 billion and $5.775 billion. A conference call is scheduled to discuss these results further.
Read more →-OPCH
Apr 8, 2026Option Care Health to Announce First Quarter 2026 Financial Results and Host Conference Call
Option Care Health Inc. will announce its first quarter 2026 financial results on April 30, 2026. The company will host a conference call at 8:30 a.m. E.T. to discuss the results. Investors can pre-register for the call and access a live audio webcast.
Read more →-OPCH
Feb 24, 2026▼ -6.3%on this news
OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR FOURTH QUARTER AND FULL YEAR 2025
Option Care Health, Inc. reported its financial results for the fourth quarter and the full year of 2025, revealing a net revenue increase of 13.0% for the full year. However, despite the revenue growth, net income saw a decrease of 2.0% year-over-year. The company also highlighted significant stock repurchases amounting to $402 million, indicating strong cash flow and investor confidence. Looking ahead, Option Care Health anticipates further growth, projecting 2026 revenues between $5.8 billion and $6.0 billion.
Read more →-OPCH
Jan 22, 2026Option Care Health to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call
Option Care Health Inc. will announce its fourth quarter and full year 2025 financial results on February 24, 2026, before market opening. The management team will host a conference call at 8:30 a.m. E.T. to discuss the results. Participants can pre-register for the call and access a live audio webcast.
Read more →-OPCH
Jan 12, 2026OPTION CARE HEALTH ANNOUNCES PRELIMINARY FOURTH QUARTER & FULL YEAR 2025 FINANCIAL RESULTS AND PRELIMINARY FINANCIAL GUIDANCE FOR FULL YEAR 2026
Option Care Health has announced its preliminary fourth quarter and full year 2025 financial results, along with preliminary guidance for 2026. The company expects to provide more detailed guidance during its upcoming earnings call. Additionally, the company's board has approved an increase in the share repurchase program from $500 million to $1 billion, emphasizing its commitment to returning value to shareholders. Investor engagement will continue with a presentation at the J.P. Morgan Healthcare Conference in January.
Read more →-OPCH
Oct 30, 2025▼ -8.6%on this news
OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2025
Option Care Health, Inc. announced its financial results for the third quarter ended September 30, 2025, reporting a net revenue of $1.435 billion, reflecting a 12.2% increase year-over-year. Despite the revenue growth, net income experienced a decrease of 3.8%. The company also provided an updated financial guidance for the full year, expecting net revenue between $5.60 billion and $5.65 billion. CEO John C. Rademacher highlighted the company's strong performance amid a dynamic regulatory environment.
Read more →-OPCH
Aug 20, 2025Option Care Health Announces Chief Financial Mike Shapiro to Step Down After 10 Years With the Company; Meenal Sethna Named EVP and CFO
Option Care Health has announced a leadership transition with Meenal Sethna taking over as Chief Financial Officer effective October 1, 2025, succeeding Mike Shapiro after a decade-long tenure. Shapiro will remain with the company as a Strategic Advisor until at least the first quarter of 2026. Sethna, who has extensive experience in finance and accounting across multiple industries, expressed her enthusiasm for joining the company and contributing to its growth and value creation. The transition is seen as a strategic move to sustain the company's positive momentum in the infusion services sector.
Read more →-OPCH
Jul 30, 2025OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE SECOND QUARTER ENDED JUNE 30, 2025
Option Care Health reported a strong financial performance for the second quarter of 2025, with net revenue increasing by 15.4% year-over-year, totaling $1,416.1 million. Despite a slight decrease in net income from $53.0 million in the previous year to $50.5 million, adjusted diluted earnings per share rose by 10.8%. The company has also updated its full-year guidance, expecting net revenue between $5.50 billion and $5.65 billion. CEO John C. Rademacher highlighted the team's resilience in a dynamic marketplace.
Read more →-OPCH
Apr 29, 2025▼ -6.9%on this news
OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2025
Option Care Health, Inc. reported its financial results for the first quarter ended March 31, 2025, highlighting a significant increase in net revenue to $1.333 billion, up 16.3% from the previous year. The gross profit also rose to $263.1 million, although it represented a slight decline in percentage of revenue compared to last year. Notably, adjusted net income improved to $67.1 million and the company successfully repurchased approximately $100 million in stock during the quarter. The company is optimistic about 2025, adjusting their financial guidance to project a net revenue between $5.4 billion and $5.6 billion.
Read more →-OPCH
Feb 26, 2025OPTION CARE HEALTH REPORTS FINANCIAL RESULTS FOR FOURTH QUARTER AND FULL YEAR 2024
Option Care Health reported robust financial results for the fourth quarter and full year 2024, with a significant increase in net revenue and adjusted diluted earnings per share. Q4 2024 net revenue rose to $1.346 billion, reflecting a year-over-year increase of 19.7%. However, full year net income decreased to $211.8 million, down from $267.1 million in 2023. The company also anticipates positive growth for 2025, projecting net revenues between $5.3 billion and $5.5 billion.
Read more →-OPCH
Jan 13, 2025▲ +15.5%on this news
OPTION CARE HEALTH ANNOUNCES PRELIMINARY FINANCIAL RESULTS FOR FOURTH QUARTER AND FULL YEAR 2024 AND PRELIMINARY FINANCIAL EXPECTATIONS FOR FULL YEAR 2025
Option Care Health, Inc. announced preliminary financial results for the fourth quarter and full year 2024, including guidance for 2025. The company anticipates a negative gross profit impact due to pricing adjustments related to Stelara. Further details will be provided in a financial call scheduled for February 2025. Additionally, Option Care concluded a $90 million share repurchase program and has initiated a new $500 million program.
Read more →-OPCH
Oct 30, 2024▼ -22.8%on this news
OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2024 BANNOCKBURN, IL.
Option Care Health, the largest independent provider of home and alternate site infusion services, announced its financial results for Q3 2024, reporting a net revenue of $1,278.5 million, up 17.0% from the previous year. Despite the revenue increase, net income and adjusted net income experienced declines of 4.3% and 3.2%, respectively. The company is facing supply chain disruptions due to Hurricane Helene, which will adversely affect its financial guidance for the fourth quarter. Option Care Health maintains a strong cash flow from operations and has repurchased significant amounts of its stock.
Read more →About Option Care Health, Inc.
Headquarters3000 LAKESIDE DR, BANNOCKBURN, IL, 60015
BIOPHARMAWATCH ELITE PLUS
Trade the next OPCH catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $19/mo billed annually.
Cancel anytime